Gene · 1131
Papers4,237
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 4,237
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PERfect Day: reversible and dose-dependent control of circadian time-keeping in the mouse suprachiasmatic nucleus by translational switching of PERIOD2 protein expression. | Eur J Neurosci | 2024 | 39300693 | PubTator, text mining | PubMed |
| Darifenacin: a promising chitinase 3-like 1 inhibitor to tackle drug resistance in pancreatic ductal adenocarcinoma. | Cancer Chemother Pharmacol | 2024 | 39225813 | PubTator, text mining | PubMed |
| An Updated Structure of Oxybutynin Hydrochloride. | Adv Sci (Weinh) | 2024 | 39225443 | PubTator, text mining | PubMed |
| Predicting novel targets with Bayesian machine learning by integrating multiple biological signatures. | Chem Sci | 2024 | 39170720 | PubTator, text mining | PubMed |
| In situ structural determination of cyanobacterial phycobilisome-PSII supercomplex by STAgSPA strategy. | Nat Commun | 2024 | 39169020 | PubTator, text mining | PubMed |
| CHRM3 (rs2165870) gene polymorphism is related to postoperative vomiting in female patients undergoing laparoscopic surgery. Prospective observational study. | PLoS One | 2024 | 39163289 | PubTator, text mining | PubMed |
| Deepening insights into cholinergic agents for intraocular pressure reduction: systems genetics, molecular modeling, and in vivo perspectives. | Front Mol Biosci | 2024 | 39130374 | PubTator, text mining | PubMed |
| Suppressing Charge Extraction Loss in Quantum Dot Infrared Photovoltaics by Optimizing the Charge Transport Layer. | J Phys Chem Lett | 2024 | 39116387 | PubTator, text mining | PubMed |
| Tongxieyaofang Decotion Alleviates IBS by Modulating CHRM3 and Gut Barrier. | Drug Des Devel Ther | 2024 | 39081703 | PubTator, text mining | PubMed |
| lncRNA signature mediates mitochondrial permeability transition-driven necrosis in regulating the tumor immune microenvironment of cervical cancer. | Sci Rep | 2024 | 39075098 | PubTator, text mining | PubMed |
| The Role of Muscarinic Acetylcholine Receptor M3 in Cardiovascular Diseases. | Int J Mol Sci | 2024 | 39062802 | PubTator, text mining | PubMed |
| Olanzapine Modulate Lipid Metabolism and Adipose Tissue Accumulation via Hepatic Muscarinic M3 Receptor-Mediated Alk-Related Signaling. | Biomedicines | 2024 | 39061977 | PubTator, text mining | PubMed |
| Unlocking the potential of soil microbial communities for bioremediation of emerging organic contaminants: omics-based approaches. | Microb Cell Fact | 2024 | 39054471 | PubTator, text mining | PubMed |
[Retracted] MicroRNA‑30e inhibits adhesion, migration, invasion and cell cycle progression of prostate cancer cells via inhibition of the activation of the MAPK signaling pathway by downregulating CHRM3. | Int J Oncol | 2024 | 39027991 | PubTator, text mining | PubMed |
| Protocol to create isogenic disease models from adult stem cell-derived organoids using next-generation CRISPR tools. | STAR Protoc | 2024 | 39003744 | PubTator, text mining | PubMed |
| An Updated Structure of Oxybutynin Hydrochloride. | bioRxiv | 2024 | 38895300 | PubTator, text mining | PubMed |
| Conformation- and activation-based BRET sensors differentially report on GPCR-G protein coupling. | Sci Signal | 2024 | 38889226 | PubTator, text mining | PubMed |
| Late Treatment With Autologous Expanded Regulatory T-cell Therapy After Alemtuzumab Induction Is Safe and Facilitates Immunosuppression Minimization in Living Donor Renal Transplantation. | Transplantation | 2024 | 38845088 | PubTator, text mining | PubMed |
| Image-based discrimination of the early stages of mesenchymal stem cell differentiation. | Mol Biol Cell | 2024 | 38837346 | PubTator, text mining | PubMed |
| Stable Near-Infrared Photoluminescence of Hexagonal-Shaped PbS Nanoparticles with 1-Dodecanethiol Ligands. | Materials (Basel) | 2024 | 38793447 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1131/papers?page=7